Catalyst Brief

← Calendar

Readoutin 163d

Takeda — Zasocitinib

Phase 3 primary completion: A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines.

Date
May 2027
Type
Readout
Indication
Psoriatic Arthritis

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from Takeda

  1. Apr2027